Australia's Clarity Pharmaceuticals hits record high on copper supply deal

Clarity Pharmaceuticals

30/05/2024 01:57

** Shares of Clarity Pharmaceuticals  CU6.AX  rise as much
as 5.4% to a record high of A$4.85
    ** Stock set for its sixth consecutive session of gains - if
gains hold 
    ** CU6 posts its best intraday gain since May 17
    ** Clinical-stage radiopharmaceutical firm says entered into
a supply agreement with SpectronRx for the production of Cu-64
    ** Says the supply of the diagnostic copper-64 isotope is
for co's products including a pivotal Phase III clinical trial
    ** Stock has risen 142.9% this year as of last close
    

 (Reporting by Sneha Kumar in Bengaluru)
 ((Sneha.Kumar@thomsonreuters.com;))